FTC Clears Siemens Healthineers Acquisition of Corindus
The Federal Trade Commission (FTC) has waived the waiting period for Siemens Healthineers’ $1.1 billion deal to acquire Corindus Vascular Robotics.
“The early termination of the waiting period…satisfies one of the conditions to the closing of the merger,” Corindus said in an SEC filing. The deal is expected to close by the end of this year.
Combining Siemens Healthineers’ imaging and artificial intelligence tools with Corindus’ precision robotics platform “has the potential to transform the way healthcare is delivered to those suffering from cardiovascular or peripheral disease,” the robotic devicemaker said.